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The incidence of deep vein thrombosis (DVT) is
approximately 1% of the population in the United
States; DVT is thus the third most common cardio-
vascular disorder, after coronary artery disease and
stroke.1 DVT can result in pulmonary embolism
(PE) and late consequences such as chronic venous
insufficiency and the post-thrombotic syndrome.
Approximately 50% of all venous ulcers are sequelae
of DVTs.2 According to European studies, the
prevalence of stage III chronic venous insufficiency
is approximately 1.0% to 1.5% of the adult popula-
tion.3 Direct and indirect costs of its treatment are
substantial and an increasing burden for public
health budgets.4 Pulmonary scan defects, represent-
ing PE, are found in approximately 50% of docu-
mented DVT cases.5 In the United States, the total
incidence of symptomatic PE is approximately
630,000 cases per year, half the incidence of myocar-
dial infarction.6 Of these 630,000 cases, approxi-
mately 200,000 patients die, and in nearly half of
these cases, PE is the sole cause of death.6 These fig-
ures clearly underline the importance of an early
diagnosis and treatment of DVT.
The most commonly used diagnostic method is a
clinical diagnosis in combination with objective test-
ing. The most appropriate objective test is duplex
sonography, today’s gold standard, the accuracy of
which is equivalent to that of phlebography.7-16 
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Purpose: Large studies have shown that most cases referred for duplex sonography for
suspected deep vein thrombosis (DVT) have normal scan results. For medical and eco-
nomic reasons, a preselection procedure, which allows the detection of true-negative
cases before duplex scanning, is required; this procedure should be characterized by a
high sensitivity and a high negative predictive value. 
Methods: In 343 patients (398 lower extremities) with suspected DVT, the DVT proba-
bility was clinically assessed, and a whole blood D-dimer agglutination test and a duplex
scan were performed. The diagnostic sensitivities of the D-dimer test alone, a high clin-
ical DVT probability alone, and the combination of both were evaluated.
Results: The sensitivity values for the D-dimer test to diagnose proximal and distal DVTs
were 88.7% and 80.9%, the negative predictive values (NPV) were 96.3% and 97.9%, and
the specificity and the positive predictive value (PPV) were 54.8% and 49.6% and 26.6%
and 8.2%, respectively. The sensitivities of the clinical DVT probability assessment for
the diagnosis of proximal and distal DVTs were 83.9% and 66.7%, respectively; the cor-
responding NPVs were 94.9% and 96.5%, respectively. The specificity was 56.1% and
50.8%, and the PPVs were 26.1% and 7.0%, respectively. The combined use of the results
of the clinical probability assessment and the D-dimer test resulted in sensitivities for
proximal and distal DVTs of 98.4% and 90.5%, NPVs of 99.3% and 98.6%, a specificity
of 43.4% and 38.4%, and PPVs of 24.3% and 7.6%, respectively.
Conclusion: The combined use of a clinical DVT probability assessment scheme and the
D-dimer test largely avoids false negative results, has a high sensitivity and NPV, helps
to reduce the costs of DVT diagnosis, and may, in the future, be useful as a preselection
procedure before duplex sonography. (J Vasc Surg 1999;30:929-35.)
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An unstructured clinical evaluation alone is unre-
liable, with a low sensitivity and a very poor speci-
ficity.17 As many as 75% of patients with suspected
DVT are subsequently found to have a non-throm-
botic cause of their leg pain.18,19 The nonselective
use of duplex sonography in these patients is time-
consuming and expensive. A preselection procedure
that reliably eliminates most of the true-negative
cases could effectively reduce the number of duplex
scans required.
Recently, the measurement of D-dimers, products
that are formed when cross-linked fibrin, contained in
a thrombus, is proteolyzed by plasmin, has been used
for this purpose.20,21 Various D-dimer assays are avail-
able, including enzyme-linked immunoabsorbent
assays (ELISAs), latex assays, and whole blood agglu-
tination tests. The aim of this project was to examine
whether a cheap and simple-to-use whole blood agglu-
tination D-dimer test, with proven low between-assay
variance and low interobserver variability,22 can pro-
vide a reliable DVT preselection procedure before
duplex sonography, alone or in combination with a
specifically structured clinical evaluation.
METHODS
Patient sample. All consecutive patients with
suspected DVT, referred to the Department of
Angiology at the University of Basel between April
and July 1997, were included in the study. In this
period, there were 360 patients; complete informa-
tion could be obtained for 343 of them.
Clinical evaluation. The clinical evaluation was
performed by a physician who was blinded to the
results of D-dimer testing. The clinical assessment
was based on a clinical prediction guide published by
Wells et al in 1995.18 A simplified version of this pre-
diction guide, which can be easily used under gener-
al practice conditions, was validated and published in
1997.23 The system takes into account whether
there is active cancer, whether there is paralysis,
paresis, or plaster immobilization of the lower leg,
whether the patient was bedridden for more than 3
days recently or has had major surgery within 4
weeks, and whether there is localized tenderness
along the deep venous system, an entirely swollen
leg, a calf swelling of more than 3 cm, a pitting
edema, or collateral superficial veins. The presence
of each of these factors gives one point; the presence
of a valid alternative diagnosis accounts for minus
two points. A total of zero or fewer points designates
a low clinical probability, a total of one or two points
designates a medium clinical probability, and a total
of three or more points designates a high clinical
probability. From the literature, it can be expected
that the prevalence of DVT for the three Wells prob-
ability groups (low, medium, high) ranges between
3% and 10%, 17% and 33%, and 75% and 85%,
respectively.18,23,24 To facilitate the analysis, the two
groups with the higher expected DVT prevalence
(ie, the moderate and the high Wells probability
groups) were pooled together in this study, giving
only two probabilities, low and high.
Laboratory tests. An agglutination D-dimer test
(SimpliRED, Agen Biochemicals, Queensland,
Australia) was performed by the same study nurse,
although the test could be reliably performed by any
medical staff member. A detailed description of the
SimpliRED methodology is available elsewhere.25 In
summary, a blood drop from a finger prick was mixed
with the SimpliRED test reagent for 2 minutes; the
test was considered positive when blood agglutination
occurred. Theoretically, the test allows for a semi-
quantitative interpretation, distinguishing no aggluti-
nation, minor agglutination, and major agglutination.
In this study, however, the test was judged positive or
negative with the occurrence or nonoccurrence of
agglutination, independent of the agglutination level.
Diagnostic deep vein thrombosis test (duplex
sonography). After clinical assessment and the D-
dimer test, all patients underwent systematic duplex
evaluation of the symptomatic leg (Doppler studies
were also performed in the asymptomatic leg for ref-
erence signal reasons; patients referred for screening
studies were not included in this trial). The sonog-
rapher was blinded to the results of the clinical
assessment and the D-dimer testing. The pelvic veins
and the inguinal and the femoral (deep and superfi-
cial) veins were scanned with the patient in a supine
position. The popliteal segment was scanned from a
posterior position, with the patient lying on his
abdomen. The distal venous segment, including the
posterior tibial veins, the peroneal veins, the gas-
trocnemius, and the soleus veins, were scanned with
the patient in a sitting position. Duplex criteria for a
venous thrombosis included the visualization of a
thrombus on B-mode, the lack of venous compress-
ibility, and the lack of Doppler-assessed flow signals
distal to the suspected site of thrombosis.
The duplex scanner used was an ATL HDI 3000
(Advanced Technology Laboratories, Bothell, Wash)
with a 7- to 10-MHZ linear, a 4- to 7-MHZ curved,
or a 2.2- to 3.5-MHZ phased array scanhead,
depending on the anatomical situation and the nec-
essary depth of penetration. The (duplex) Doppler
unit was a pulsed Doppler with a 2.0- to 5.0-MHZ
scanning frequency.
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Thromboses were classified as proximal or distal,
depending on whether they were located proximally
or distally to the confluence of the posterior tibial
and the peroneal veins.
Evaluation of results. Duplex sonography was
used as the gold standard in this study. The sensitiv-
ity, the specificity, and the negative and positive pre-
dictive values (NPV, PPV) of the D-dimer test, the
clinical DVT probability assessment, and the combi-
nation of the D-dimer test and the clinical DVT
evaluation were calculated against this standard. The
Basel Medical School Quality Control Act demands
proof of diagnostic accuracy before a diagnostic pro-
cedure can be accepted as the in-house gold stan-
dard. Compared with venography, this department’s
duplex sensitivity for proximal DVT was 97%, the
specificity 96%, and the NPVs and PPVs 98% and
94%, respectively. For distal DVTs, the sensitivity
comes to 94%, the specificity to 91%, and the NPVs
and PPVs to 94% and 90%, respectively (in-house,
unpublished data).
RESULTS
Total population. Altogether, 417 lower
extremities of 360 patients were investigated; 398
extremities (343 patients) were included in the
analysis. The results for 19 extremities were exclud-
ed because of missing data (no independent D-
dimer testing available). Fifty-five patients were
referred with a suspected bilateral DVT. Conclusive
duplex scans were achieved in all cases. The age of
the thrombi, whether acute or chronic, was not sys-
tematically assessed, because clinical information is
known to be unreliable and duplex data are insuffi-
cient. Demographic data of the patient sample are
summarized in Table I.
Duplex examination. In 398 lower extremities,
83 DVTs (20.8%) were diagnosed. Of these, 21
(5.3%) were in the calf, and 62 (15.5%) were proxi-
mal. In 17 more cases, an isolated superficial throm-
bophlebitis was diagnosed; these cases were not
included as positives in the main study analysis.
D-dimer testing. Of 398 extremities, the D-
dimer test was positive in 207 (52.0%) and negative in
191 (48.0%). Compared with duplex sonography, 72
results were classified as true positive, 135 as false pos-
itive, 180 as true negative, and 11 as false negative.
The overall sensitivity was 86.7%; the NPV was
94.2%. The overall specificity and PPV were poor
and amounted to 57.1% and 34.8%, respectively.
For proximal and distal DVTs, the sensitivities were
88.7% and 80.9%, the NPVs were 96.3% and
97.9%, and the specificity and the PPV were 54.8%
and 49.6% and 26.6% and 8.2%, respectively.
Results for D-dimer testing are summarized in
Table II.
Eleven DVTs were missed with the D-dimer test.
These included four in the calf and seven proximal
thromboses. The distal lesions consisted of one
extended peroneal and posterior tibial thrombosis
each; the remaining two distal DVTs were isolated,
small lesions. The seven proximal thromboses con-
sisted of four partially occluding, isolated popliteal
DVTs, one phlebitis of the greater saphenous vein
with a thrombus extending into the common
femoral vein, one small, isolated thrombus of the
superficial femoral vein in a patient with a marked
postphlebitic syndrome, and one extended throm-
bus of the superficial femoral vein, which had been
present for more than 10 days, according to the
medical history.
The inclusion of cases with isolated superficial
thrombophlebitis and no evidence of DVT did not
markedly change the D-dimer diagnostic accuracy.
The overall sensitivity was 84%, the NPV was 91.6%,
and the specificity and the PPV were 58.7% and
40.6%, respectively.
In the subgroup of patients with a low clinical
probability (n = 285), 18 proximal and 10 distal
DVTs were revealed by means of duplex sonogra-
phy; 17 of the 18 proximal and eight of the 10 dis-
tal cases were D-dimer positive.
Clinical deep vein thrombosis probability
assessment. The sensitivities of a high DVT proba-
bility, as assessed clinically in diagnosing proximal and
distal DVT, were 83.9% and 66.7%, respectively. The
corresponding NPVs were 94.9% and 96.5%, respec-
tively. Specificities came to 56.1% and 50.8%, and
PPVs amounted to 26.1% and 7.0%, respectively.
Combined use of D-dimer testing and clinical
DVT probability assessment. This pretest proce-
dure was considered positive when the clinical
assessment revealed a high DVT probability, the D-
dimer test was positive, or both. With this proce-
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Table I. Details of the patient sample
Number of patients (n) 343
Number of extremities (n) 398
Median age (years) 61
Age range (years) 17 to 94
Sex
Men (n, %) 134, 39%
Women (n, %) 209, 61%
Outpatients (n, %) 165, 48%
Inpatients (n, %) 178, 52%
dure, the number of false-negative results dropped
from 11 to three, resulting in sensitivities for proxi-
mal and distal DVTs of 98.4% and 90.5% and NPVs
of 99.3% and 98.6%, respectively. Specificities
dropped by approximately 10% (43.4%, 38.4%),
whereas PPVs remained largely unchanged (24.3%,
7.6%). The three false-negative results consisted of
one proximal DVT with isolated thrombosis of the
popliteal vein and two distal DVTs, isolated small
lesions, one in the posterior tibial and one in the
peroneal vein segment. Results for the combined use
of D-dimer testing and the clinical evaluation are
summarized in Table III.
SUBGROUP ANALYSIS
Inpatients. The overall DVT prevalence was
21.6%; proximal DVTs were found in 15.8% of
cases, and distal DVTs were found in 5.8% of cases.
The D-dimer sensitivity for all DVTs was 86.6%, the
NPV was 93.3%, and the specificity and the PPV
were 51.5% and 33.1%, respectively. For the com-
bined pretest probability algorithm, the DVT sensi-
tivity for all DVTs was 95.5%, the NPV was 97.2%,
and the specificity and the PPV were 44.8% and
32.3%, respectively. 
Outpatients. The overall DVT prevalence was
20.0%; proximal DVTs were found in 15.3% of
cases, and distal DVTs were found in 4.7% of cases.
The D-dimer sensitivity for all DVTs was 86.8%, the
NPV was 95.0%, and the specificity and the PPV
were 63.1% and 37.0%, respectively. For the com-
bined pretest probability algorithm, the DVT sensi-
tivity for all DVTS was 97.4%, the NPV was 98.6%,
and the specificity and the PPV were 46.7% and
28.8%, respectively. 
DISCUSSION
The earliest possible diagnosis of DVT and the
prevention of its complications and consequences,
such as PE and postphlebitic syndromes, are vital
from both the medical and the socioeconomic
points of view. A considerable body of literature sup-
ports the view that today’s gold standard for the
diagnosis of DVT is duplex sonography, which is a
noninvasive test, with an accuracy equivalent to that
of phlebography when carried out by an experienced
sonographer.7-16 Potential alternatives include B-
mode compression sonography and impedance
plethysmography.26-28 However, the sensitivity and
the PPV of plethysmography are lower than those of
compression sonography,26 and compression sonog-
raphy was shown to have a low sensitivity for distal
DVT.27,28 These problems are largely overcome
with duplex sonography. The only disadvantages of
duplex sonography are that the technique is time
consuming and not inexpensive and that results
depend on the skills and experience of the sonogra-
pher. 
To avoid unnecessary referrals for duplex sonog-
raphy, a bedside preselection procedure would be
helpful in reliably selecting those patients who do
not have DVT, so that they do not need to be
referred for duplex scanning. This preselection pro-
cedure should be characterized by a high sensitivity
and a high NPV, to ensure that the number of false-
negative results will be reduced to an acceptable
minimum. The specificity and the PPV are of sec-
ondary importance, because all positive cases,
whether true or false, will undergo duplex sonogra-
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Table II. D-dimer test: Distribution of true- and
false-positive and true- and false-negative results
and related sensitivity, specificity, negative predic-
tive value, and positive predictive value
All DVTs Proximal DVTs Distal DVTs
True positive 72 55 17
False positive 135 152 190
True negative 180 184 187
False negative 11 7 4
Sensitivity (%) 86.7 88.7 80.9
Specificity (%) 57.1 54.8 49.6
NPV (%) 94.2 96.3 97.9
PPV (%) 34.8 26.6 8.2
DVT, Deep vein thrombosis; NPV, negative predictive value;
PPV, positive predictive value.
Table III. Distribution of true- and false-positive
and true- and false-negative results from combined
screening procedure (positive results from D-dimer
test, high probability from clinical assessment, or
both) and resulting sensitivity, specificity, negative
predictive value, and positive predictive value
All patients Proximal DVTs Distal DVTs
True positive 80 61 19
False positive 171 190 232
True negative 144 146 145
False negative 3 1 2
Sensitivity (%) 96.4 98.4 90.5
Specificity (%) 45.7 43.4 38.4
NPV (%) 98.0 99.3 98.6
PPV (%) 31.9 24.3 7.6
DVT, Deep vein thrombosis; NPV, negative predictive value;
PPV, positive predictive value.
phy. From a cost-related point of view, however, a
high specificity would reduce the number of false-
positive pretest results and thus the number of
duplex scans required.
The rapid D-dimer test is a promising, easy-to-
use screening procedure that does not require spe-
cific training of the staff members performing the
test. However, with sensitivities for proximal and
distal DVTs of 88.7% and 80.9%, the test has some
basic deficiency in diagnostic accuracy, although
NPVs amounted to 96.3% and 97.9%. In our series,
there were 11 false-negative results, which all
occurred with small, localized thrombi or older
lesions with estimated ages close to 2 weeks. It is
well known that the level of D-dimers depends on,
among other things, the extent of a fibrin clot,
which explains why very small thrombi may have a
D-dimer level below a predefined (diagnostic)
threshold and therefore will be missed.20 Lowering
the threshold is not a solution, because it will result
in an unacceptably high number of false-positive
results. Also, it is well known that the presence of D-
dimers decreases with time and that the test may
become negative when the interval between event
and screening exceeds 2 to 3 weeks.22
In the literature, there is no agreement on the
clinical importance of such (small or older) lesions.
Thrombi with an age of approximately 14 days may
be well organized and thus carry a lower risk for PE.
Also, the risk related to small thrombi, particularly
when located in the lower-leg deep venous system, is
often considered low.28,29 When observed longitu-
dinally, these thrombi may show recurrence and pro-
gression rates as high as 30%30,31 and may thus be
the source for PE. In our opinion, the detection of
these thrombi is therefore important, because they
require anticoagulation. Thus, although explained,
the number of false-negative results reported in this
study remains a reason for concern.
Results of the D-dimer test reported in this paper
are in agreement with the literature.20,21,32 Ginsberg
et al published a NPV of 97.2% for all DVT loca-
tions, but still concluded that, to further reduce the
number of false-negative results, the D-dimer test
should be routinely combined with impedance
plethysmography.21 However, because the latter
requires a hospital environment, there should be
more practical alternatives. One alternative would be
to use ELISA D-dimer tests, rather than whole
blood agglutination tests. For ELISA tests, slightly
higher sensitivities were reported.33 On the other
hand, the ELISA test cannot be used as a fast, sim-
ple, and cheap bedside procedure. A second alterna-
tive would be the use of the whole blood D-dimer
test in combination with another easy-to-use bed-
side screening procedure, such as a clinical DVT
probability assessment scheme. In this context, the
Wells system, particularly in its simplified form,23
becomes attractive, because it does not require any
information that is not available with the venous
routine examination. Also, the structure of the sys-
tem is easy to understand, and it does not require
specific training; thus, it can be easily used under
general practice conditions, although it has to be
acknowledged that the system may not be well
known in the general medical community yet. The
use of the whole blood D-dimer test in combination
with the Wells DVT probability assessment scheme
as a screening procedure (meaning to refer only
those patients for duplex sonography in whom either
the D-dimer test, the Wells criteria, or both were
positive) results in a reduction of false-negative find-
ings from 11 to three, a figure that is highly satisfac-
tory and acceptable for a screening test. The speci-
ficity and the PPV for this combined procedure were
poor, as may be expected for a preselection test.
Also, the NPVs reported in this paper are only valid
for the DVT prevalence found in our patient sample.
However, the prevalence figures reported here were
in agreement with the literature,34 and there is some
probability that the patient sample of this study is
representative of an average vascular laboratory pop-
ulation, although it must be recognized that with an
increasing DVT prevalence NPVs would drop.
With a combined pretest probability algorithm,
the discriminating power of its components is impor-
tant. It might be assumed that, particularly in case of
a low clinical probability, additional D-dimer testing
will have little impact on the patient’s treatment.
However, this consideration is disproved by 25 of the
28 duplex positive DVT cases, all of which had a low
clinical probability, being D-dimer positive, showing
that the impact of both components in the algorithm
is equivalent and that neglecting to perform the D-
dimer testing would have led to an unacceptably high
number of false-negative pretest results.
From a theoretical point of view, it may be
doubted that the proposed pretest procedure will
work in inpatients and in outpatients, because the
number of positive D-dimer tests (for other than
DVT reasons) is expected to be higher in inpatients.
Also, the NPV, as reported for the overall study sam-
ple, may differ between groups because of an expect-
ed higher DVT prevalence in inpatients. These
hypotheses, however, were not supported by the
results of this study. 
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If the preselection procedure had been applied to
this study’s patient sample, the number of duplex
scans would have been reduced from 398 to 254.
With charges of approximately $178 per scan in
Switzerland, the total saving would have amounted
to approximately $25,700. This saving potential has
to be counterbalanced by the costs related to the D-
dimer testing. The costs for one test in Switzerland
is approximately $4.30, with a total for all patients of
$1600. Because the test can be performed in
approximately 5 minutes, additional time-related
staff costs are not substantial. The figures given are
country specific (Switzerland). However, there is
clear evidence that the use of the pretest selection
procedure will result in a substantial reduction of
costs, particularly when it is taken into account that
further related direct and indirect costs (such as time
to refer a patient for a diagnostic study, loss of pro-
ductivity with a patient having to spend time for
additional tests, etc.) were not considered in this
cost estimation.
CONCLUSION
In case of suspected DVTs, the results of this
study support the diagnostic strategy of a two-step
procedure, in which the use of a rapid D-dimer
agglutination test with a structured clinical assess-
ment of the DVT probability is used as a preselec-
tion procedure before a diagnostic test, such as
duplex sonography. The preselection procedure is
characterized by an excellent sensitivity and negative
predictive value, largely avoids false-negative results,
facilitates the overall diagnostic process, and helps to
save costs without sacrificing diagnostic accuracy.
However, further studies are required to test the
validity of this pretest algorithm prospectively.
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